GALLIVANONE, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 2.137
NA - Nord America 1.382
EU - Europa 505
SA - Sud America 378
AF - Africa 46
OC - Oceania 6
Totale 4.454
Nazione #
US - Stati Uniti d'America 1.322
SG - Singapore 921
CN - Cina 432
BR - Brasile 310
HK - Hong Kong 240
VN - Vietnam 208
IT - Italia 146
FR - Francia 128
KR - Corea 86
JP - Giappone 62
GB - Regno Unito 49
IN - India 40
BD - Bangladesh 34
NL - Olanda 33
FI - Finlandia 31
DE - Germania 28
CA - Canada 27
MX - Messico 19
AR - Argentina 18
ID - Indonesia 18
EC - Ecuador 16
IQ - Iraq 16
TR - Turchia 15
ZA - Sudafrica 12
IL - Israele 11
RU - Federazione Russa 11
UA - Ucraina 11
VE - Venezuela 9
AT - Austria 8
CL - Cile 8
CO - Colombia 8
EG - Egitto 8
PK - Pakistan 8
ES - Italia 7
MA - Marocco 7
PH - Filippine 6
UZ - Uzbekistan 6
CR - Costa Rica 5
IE - Irlanda 5
KE - Kenya 5
PL - Polonia 5
PT - Portogallo 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DK - Danimarca 4
JO - Giordania 4
KG - Kirghizistan 4
SA - Arabia Saudita 4
AL - Albania 3
CH - Svizzera 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
RS - Serbia 3
SI - Slovenia 3
SV - El Salvador 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BH - Bahrain 2
ET - Etiopia 2
GE - Georgia 2
LV - Lettonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
SE - Svezia 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
ZM - Zambia 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
ML - Mali 1
MT - Malta 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.454
Città #
Santa Clara 631
Singapore 529
Hong Kong 236
Hefei 167
San Jose 140
Beijing 94
Lauterbourg 92
Seoul 84
Ashburn 79
Ho Chi Minh City 77
Los Angeles 61
Tokyo 50
Hanoi 37
São Paulo 31
New York 30
Dallas 25
Milan 22
Buffalo 20
Helsinki 14
Rio de Janeiro 13
Da Nang 11
Istanbul 11
Johannesburg 10
Lappeenranta 10
Phoenix 10
Baghdad 9
Minamishinagawa 9
Montreal 9
Quito 9
Rome 9
Brescia 8
Brooklyn 8
Chennai 8
Council Bluffs 8
Guangzhou 8
Haiphong 8
Manchester 8
Newark 8
Nuremberg 8
Bari 7
Curitiba 7
Orem 7
Paris 7
San Martino in Rio 7
Atlanta 6
Guarulhos 6
London 6
Poplar 6
Porto Alegre 6
Tashkent 6
Thái Nguyên 6
Toronto 6
Turku 6
Amsterdam 5
Arese 5
Belo Horizonte 5
Bengaluru 5
Chicago 5
Dhaka 5
Frankfurt am Main 5
Guayaquil 5
Houston 5
Hải Dương 5
Indianapolis 5
Jakarta 5
Kyiv 5
Mexico City 5
Munich 5
Naples 5
Padua 5
Pisa 5
Turin 5
Amman 4
Bishkek 4
Biên Hòa 4
Boston 4
Buenos Aires 4
Dublin 4
Düsseldorf 4
Lucca 4
Marseille 4
Monza 4
Nairobi 4
Quận Một 4
Salvador 4
Seattle 4
Warsaw 4
Belgrade 3
Bắc Giang 3
Cairo 3
Charlotte 3
City of London 3
Franca 3
Franco da Rocha 3
Hamilton 3
Joinville 3
Manassas 3
Montesilvano Marina 3
Mumbai 3
New Delhi 3
Totale 2.884
Nome #
Assessing Spectral Metrics to Estimate Aquatic Plant Diversity from Hyperspectral Imaging: Preliminary Results 121
Exploring spectral and phylogenetic diversity links with functional structure of aquatic plant communities 113
Acute Inescapable Stress Rapidly Increases Synaptic Energy Metabolism in Prefrontal Cortex and Alters Working Memory Performance. 91
AI applications to medical images: From machine learning to deep learning 82
Bioinformatics clouds for high-throughput technologies 76
Estimating Aquatic Plant Diversity Using Spectral Metrics from Drone Hyperspectral Imaging 74
Circulating microRNAs as Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy: A Pilot Study 72
Relationship between 18F-FDG PET SUV with Partial Volume Correction and Histology in Gastric and Gastro-Oesophageal Cancer 68
Influence of canopy structure and illumination geometry on spectral anisotropy of aquatic vegetation in ultra-high resolution hyperspectral imagery 66
Impact of Radiometric Variability on Ultra-High Resolution Hyperspectral Imagery Over Aquatic Vegetation: Preliminary Results 66
Targeted radionuclide therapy: frontiers in theranostics 63
Statistical voxel-based analysis of [F-18]FDG PET animal studies for the estimation of glucose metabolism in stress conditions 60
PET-CT FDG quantification of oncological lesions: a PVE correction method from measured L/B and lesion volume 58
Agarose/Sucrose Gel Breast Phantom for Validation of Quantitative Methods in Diffusion Weighted Imaging 58
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia 57
Clinical assessment of a recovery coefficients-based partial volume correction in 18F-FDG PET-CT oncological studies 56
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions 55
A tri-modal tissue-equivalent anthropomorphic phantom for PET, CT and multi-parametric MRI radiomics 55
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways 54
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 54
18F-FDG PET/CT in gastro-oesophageal cancer: correlations between Partial Volume Corrected Body-Weight Standardized Uptake Value (PVC-SUVBW) and biological characteristics of primitives 53
Prognostic Value of pre-therapy 18FDG PET/CT for the Outcome of 18FDG PET-guided SIB-IMRT in Patients with Head and Neck Cancer 53
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study 53
Secreted miR‐153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer 50
Circulating microRNA: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study. 49
Effects of functional type and angular configuration on reflectance anisotropy of aquatic vegetation in ultra-high resolution hyperspectral imagery 48
Correlation between 18FDG PET SUV with Partial Volume Correction and MRS Choline signal integral in breast cancer 47
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD 47
statistical parametric mapping for activations studies in rats 46
Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness 46
The impact of different 18FDG PET Healthy Subject scans for comparison with single patient in SPM analysis. 45
Machine Learning on Brain MRI Data for Differential Diagnosis of Parkinson's Disease and Progressive Supranuclear Palsy 45
Pet/mri for staging the axilla in breast cancer: Current evidence and the rationale for snb vs. pet/mri trials 45
AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomics 45
Quantitation and data analysis in hybrid PET/MRI systems 44
Prognostic value of pre-therapy 18F-FDG PET/CT for the outcome of radiotherapy treatment in patients with head and neck cancer 43
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer 43
Prognostic value of quantitative 18F-FDG PET biomarkers in breast cancer 43
Parameters influencing PET imaging features: A phantom study with irregular and heterogeneous synthetic lesions 42
Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer. 42
A Partial Volume Effect Correction Tailored for (18)F-FDG-PET Oncological Studies 42
A Graph-Based Method for PET Image Segmentation in Radiotherapy Planning: A Pilot Study 41
A graph-based method for biological target volume segmentation 41
A method for manufacturing oncological phantoms for the quantification of 18F-FDG PET and DW-MRI studies 41
Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer. 39
An anthropomorphic phantom for advanced image processing of realistic 18F-FDG PET-CT oncological studies 39
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD 38
Imaging Imagination 38
Validation of normal control database from different CT-PET scanners for SPM single-subject analysis of 18FDG PET brain images 38
Acute stress studies in rats by 18FDG PET and SPM 37
PVE correction in PET-CT whole-body oncological studies from PVE-affected images 37
Touch-SUV (Licenza Software) 37
Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease 37
Metabolic impact of partial volume correction of [18F]FDG PET-CT oncological studies on the assessment of tumor response to treatment. 37
Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and 18 F-FDG-PET/CT: Correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade 36
18F-FDG PET in gastro-oesophageal cancer: clinical impact of Partial Volume Correction in treatment monitoring 35
E-Health Decision Support Systems for the Diagnosis of Dementia Diseases 35
18F-FDG PET as a tool for imaging proliferation in breast cancer: correlation between partial volume-corrected SUV and MIB-1 proliferation index 35
18F-FDG PET/CT in gastro-oesophageal cancer: correlations between Partial Volume Corrected Body-Weight Standardized between Partial Volume Corrected Body-Weight Standardized primitives 35
The utility of FDG-PET in the differential diagnosis of Parkinsonism 34
Imaging of proliferation in breast cancer with 18F-FDG PET: Correlation between partial volume corrected SUV and MiB-1 proliferation index 34
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 34
Statistical voxel-based analysis of [18F]FDG PET animal studies for the estimation of glucose metabolism in stress conditions 34
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 33
Integration of quantitative biomarkers from in vivo multi-modal PET and MR studies for the diagnostic and therapeutic management of Gastric Cancer patients 33
Clinical validation of a Grid-based SPM web tool for the automatic assessment of [18F]FDG-PET brain metabolic automatic assessment of [18F]FDG-PET brain metabolic 33
An automatic segmentation method for the measurement of the functional volume of oncological lesions on MR ADC maps 33
18F-FDG relationship with histopathological and immunohistochemical data in breast cancer using SUV with or without Partial Volume Correction 33
Touchscreen-technology-assisted method for diagnostic reporting of quantitative CT-PET oncology studies 32
Integration of in vivo biomarkers with ex vivo histo-pathological and immune-histochemical data: the effect of Partial Volume Correction on PET studies. 32
Adaptive threshold method based on PET measured lesion-to-background ratio for the estimation of Metabolic Target Volume from F-18-FDG PET images 32
Biomarkers from in vivo molecular imaging of breast cancer: pretreatment F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy. 32
One-year-experience in the use of Partial Volume Correction impact on the role of 18FDG PET for the diagnosis, prognosis and therapy monitoring toward personalized medicine in oncology 32
e-services for image-based diagnosis of neurodegenerative diseases 31
Clinical assessment of a recovery coefficients based partial volume correction method: impact on SUV quantification of bone metastases in 18F-FDG PET-TC studies 31
cOuch (Licenza Software) 30
Prospective comparison of MR with diffusion-weighted imaging, Endoscopic Ultrasound, MDCT and Positron Emission Tomography-CT in the preoperative staging of oesophageal cancer: results from a pilot study. 30
A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for F-18-FDG PET preclinical studies 29
A virtual lab of integrated molecular medicine 29
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer 29
A clinically feasible, Operator Independent Partial Volume Correction for oncological 18F-FDG PET-CT studies 29
FP7-Eu project DECIDE (Diagnostic Enhancement of Confidence by an International Distributed Environment): e-services for the assisted diagnosis of neurodegenerative functional studies 29
Quantification of PET-CT 18F-FDG oncological lesions with Partial Volume Effect correction 29
A tool for the extraction of new disease biomarkers from ex vivo and in vivo data 28
A Clinical feasible, Operator Indipendent Partial Volume Correction for Oncological 18F-FDG PET-CT studies 28
A Decision Support System for the assisted diagnosis of brain tumors: A feasibility study for (18)F-FDG PET preclinical studies. 28
[18F]FDG PET/CT features for the molecular characterization of primary breast tumors 27
Accuracy, reproducibility, feasibility and clinical impact of a PVC on 18F-FDG quantification in bone metastases by PET/CT follow-up studies 27
Hybrid PET/MRI for in Vivo imaging of cancer: Current clinical experiences and recent advances 27
Feasibility and clinical impact of an Operator Independent quantification method in 18F-FDG PET/CT oncological studies. 27
STRAT 27
Feasibility of supervised machine learning technique for assisted diagnosis of cancer: application to PET studies in small animals. 27
A clinically feasible, Operator Indipendent Partial Volume Correction for oncological 18F-FDG PET-TC studies 27
Correlation between 18FDG PET SUV with Partial Volume Correction and MRS Choline signal integral in breast cancer 27
PVE correction in PET from PVE affected images. 26
An e-infrastructure for integrating translational molecular medicine. 26
Partial Volume Correction Methods Based on Measured Lesion-to-Background Ratio in PET-CT Oncological Studies. 25
Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel. 25
FP7-Eu project DECIDE (Diagnostic Enhancement of Confidence by an International Distributed Environment): e-services for the assisted diagnosis of neurodegenerative diseases. 25
Texture analysis of FDG-PET/CT images to characterize lung cancer lesions and to predict outcome in patients undergoing primary surgery: preliminary results 24
Totale 4.254
Categoria #
all - tutte 13.645
article - articoli 9.296
book - libri 153
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 402
Totale 23.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202437 0 0 0 0 0 0 0 0 4 0 33 0
2024/20251.876 6 8 128 57 574 118 35 117 39 40 412 342
2025/20262.618 139 185 235 394 521 164 402 103 145 205 125 0
Totale 4.531